Paper40161374
A novel lactylation-related gene signature to predict prognosis and treatment response in lung adenocarcinoma.
Zhang H and 7 others. Front Oncol, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. A novel lactylation-related gene signature to predict prognosis and treatment response in lung adenocarcinoma. Papers, record 40161374. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40161374
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A novel lactylation-related gene signature to predict prognosis and treatment response in lung adenocarcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38422959 | Identification of SLC2A1 as a predictive biomarker for survival and response to immunotherapy in lung squamous cell carcinoma. | Comput Biol Med | 2024 | https://conductscience.org/library/papers/38422959 | PubMed |
| 2 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 3 | 38825017 | Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma. | J Hepatol | 2024 | https://conductscience.org/library/papers/38825017 | PubMed |
| 4 | 37582358 | Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. | Cell | 2023 | https://conductscience.org/library/papers/37582358 | PubMed |
| 5 | 37457701 | Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation. | Front Immunol | 2023 | https://conductscience.org/library/papers/37457701 | PubMed |
| 6 | 35742933 | EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35742933 | PubMed |
| 7 | 38242124 | Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. | Cancer Cell | 2024 | https://conductscience.org/library/papers/38242124 | PubMed |
| 8 | 25229481 | pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. | PLoS One | 2014 | https://conductscience.org/library/papers/25229481 | PubMed |
| 9 | 37675097 | Advances in post-translational modifications of proteins and cancer immunotherapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37675097 | PubMed |
| 10 | 31582214 | LINC01419 promotes cell proliferation and metastasis in lung adenocarcinoma via sponging miR-519b-3p to up-regulate RCCD1. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/31582214 | PubMed |
| 11 | 34936872 | Protein modifications throughout the lung cancer proteome unravel the cancer-specific regulation of glycolysis. | Cell Rep | 2021 | https://conductscience.org/library/papers/34936872 | PubMed |
| 12 | 38844063 | LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma. | Cancer Lett | 2024 | https://conductscience.org/library/papers/38844063 | PubMed |
| 13 | 39137401 | H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer. | Cancer Res | 2024 | https://conductscience.org/library/papers/39137401 | PubMed |
| 14 | 37220590 | Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37220590 | PubMed |
| 15 | 38226837 | Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. | Cancer Biol Ther | 2024 | https://conductscience.org/library/papers/38226837 | PubMed |
| 16 | 39395525 | CAF-secreted LOX promotes PD-L1 expression via histone Lactylation and regulates tumor EMT through TGFβ/IGF1 signaling in gastric Cancer. | Cell Signal | 2024 | https://conductscience.org/library/papers/39395525 | PubMed |
| 17 | 38395657 | Lysine lactylation in the regulation of tumor biology. | Trends Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38395657 | PubMed |
| 18 | 33953163 | Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. | Nat Commun | 2021 | https://conductscience.org/library/papers/33953163 | PubMed |
| 19 | 37442772 | Tumor immune microenvironment-modulated nanostrategy for the treatment of lung cancer metastasis. | Chin Med J (Engl) | 2023 | https://conductscience.org/library/papers/37442772 | PubMed |
| 20 | 28455245 | RCCD1 depletion attenuates TGF-β-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells. | Cancer Lett | 2017 | https://conductscience.org/library/papers/28455245 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42955459 | Multi-cohort and single-nucleus transcriptomics identify a five-gene lactylation-related panel and a disease-dependent hepatocyte glycolysis-lactylation-related expression program in metabolic dysfunction-associated steatohepatitis. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42955459 | PubMed |
| 42905309 | RCCD1-JMJD5 coordinate histone demethylation to promote platinum resistance in non-small cell lung cancer via FN1-mediated epithelial-mesenchymal transition. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42905309 | PubMed |
| 42663294 | Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/42663294 | PubMed |
| 41890712 | A lactylation modification-related prediction model for the diagnosis of ulcerative colitis based on machine learning. | Front Immunol | 2026 | https://conductscience.org/library/papers/41890712 | PubMed |
| 41737892 | Lactylation-related genes signature panel in hepatocellular carcinoma reveals the prognostic and therapeutic optimization. | Mol Cell Oncol | 2026 | https://conductscience.org/library/papers/41737892 | PubMed |
| 41345972 | Integrated bulk and single-cell transcriptomics to develop an efferocytosis-related prognostic model for lung adenocarcinoma and validate the key gene LDHA. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/41345972 | PubMed |
| 41205015 | Lactylation-related multigene signature in multiple myeloma: integrated prognostic stratification, immune landscape profiling, and therapeutic guidance. | Immunol Res | 2025 | https://conductscience.org/library/papers/41205015 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40161374
GET https://conductscience.org/api/papers/v1/40161374/references?page=2